Table 3.
Median (range), n=18 | |
---|---|
Normal lung (%) | 7·94 (0–35) |
Acute/Exudative DAD (%) | 15·94 (0–93) |
Intermediate DAD (%) | 40·88 (1–99) |
Advanced DAD (%) | 1·88 (0–93) |
Alveolar hemorrhage (%) | 0·69 (0–10) |
Infarct (%) | 0 (0–9) |
Bronchopneumonia (%) | 0 (0–16) |
Arteriolar thrombosis (number)a | 0 (0–10) |
Capillary thrombosis (sum)b | 0 (0–5) |
DAD: Diffuse alveolar damage.
Number of vessels with thrombosis in each patient. Fourteen out of 18 COVID-19 patients presented arteriolar thrombosis.
Sum of biopsied lung sites presenting capillary thrombosis in each patient. Eight out of the 18 COVID-19 patients presented capillary thrombosis.